Douglas E. Onsi - 31 Jan 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
CEO,CFO,Pres.,GC,Treas.,&Sec., Director, 10%+ Owner
Signature
/s/ Douglas E. Onsi
Issuer symbol
LPTX
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 20:47:31 UTC
Previous filing
28 May 2021
Next filing
02 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Restricted Stock Units Award $0 +325,000 $0.000000 325,000 31 Jan 2022 Common Stock 325,000 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
F2 The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.